Please enable Javascript
Sundar Jagannath, MBBS
Articles by Sundar Jagannath, MBBS
Sundar Jagannath, MBBS, on Linvoseltamab in Relapsed or Refractory Myeloma
Melissa Badamo
Myeloma
|
April 8, 2024
The overall response rate was 71%, and the most common side effects were CRS, neutropenia, and anemia.
View More